Quarterly Archive Search

Keyword:

Content Type:

Authors:

Topic:

Date Range:

  • Health Equity Population Health

    Turf Wars: How Growth and Competitive Shocks Have Affected the Performance and Stability of Community Health Centers

    July 2025 Justin Markowski

    Context: Community health centers (CHCs) are a critical and growing part of the health care safety net, doubling over the past 15 years to expand access to essential health care services to over 31 million patients in traditionally underserved communities. However, increasingly, CHCs have opened care delivery locations in communities already served by another CHC, potentially creating competitive markets with unknown implications for how this safety net operates. More

  • Legal Barriers to Safer Smoking Supplies Cause Harm and Should Be Removed

    Population Health

    Legal Barriers to Safer Smoking Supplies Cause Harm and Should Be Removed

    July 2025 Corey Davis Amy Lieberman Czarina Behrends

    The United States continues to experience a nearly unprecedented level of drug-related health harms, with over 105,000 Americans dying of overdose in 2023 alone. Although overall overdose deaths declined slightly from 2022 to 2023, rates for Black people continued to rise. Stimulants such as cocaine and methamphetamine are increasingly involved in overdose deaths, and xylazine and other contaminants continue to be prevalent in the illicit drug supply. More

  • Commercial Determinants of Health

    Lobbying in the Shadows: A Comparative Analysis of Government Lobbyist Registers

    July 2025 Jennifer Lacy-Nichols Hedeeyeh Baradar Eric Crosbie Katherine Cullerton

    nformation about lobbying is crucial to alert the public about undue influence in government decision making. Yet, government disclosures of lobbying activities are rare internationally and vary considerably in their completeness and accessibility. Building on a framework to measure lobbying transparency, this study benchmarked national government disclosures to understand what information was shared and to develop recommendations to strengthen political transparency. More

  • Health Equity

    Incarceration and Psychiatric Emergency Department Visits Among Black Americans

    July 2025 Abhery Das Michael Esposito Tim A. Bruckner Hedwig Lee

    The justice system incarcerates nearly 2.3 million individuals in the United States. Black Americans comprise 40% of those incarcerated despite representing less than 15% of the population. Theoretical work posits that mass incarceration can erode social capital by straining social and family networks as well as inducing carceral churn and coercive mobility within Black communities. Scholars report that greater incarceration may influence population-level health, specifically in communities of color. However, previous work does not address whether incarceration, as well as the racial disparity in incarceration, corresponds with psychiatric help seeking in the Black community. More

  • Laws Governing Substance Use During Pregnancy: Next Steps for Health Equity Research

    Health Equity Opioids

    Laws Governing Substance Use During Pregnancy: Next Steps for Health Equity Research

    July 2025 Hannah L.F. Cooper Anna L. Mullany Snigdha Peddireddy Simone Wien Melvin "Doug" Livingston Whitney S. Rice Anne L. Dunlop Michael R. Kramer Madison Haiman Lasha S. Clarke Natalie D. Hernandez-Green Angélica Meinhofer

    See all articles in the special issue, Mental Health and Substance Use Challenges Facing the United States: What Can State Policymakers… More

  • Health Equity Health Insurance

    No Data, No Problem: Quantifying Latine Individuals Eligible for but Not Enrolled in Medicaid or Affordable Care Act Marketplace-Based Insurance in North Carolina

    July 2025 Gabriela Plasencia Kamaria Kaalund Olurotimi Kukoyi Viviana Martinez-Bianchi Andrea Thoumi

    Populations that identify as Latino/a/e/x or Hispanic (herein referred to as Latine) in the United States continue to face disproportion-ate health… More

  • Integrating Mental Health and Substance Use Treatment With Emergency and Primary Care: The Case of Opioid Use Disorder and Suicide

    Mental health Opioids

    Integrating Mental Health and Substance Use Treatment With Emergency and Primary Care: The Case of Opioid Use Disorder and Suicide

    July 2025 Noa Krawczyk Hillary Samples

    The United States is facing an ongoing mental health and substance use crisis. In 2023, 58.7 million US adults had a past-year mental illness, 46.3 million had a substance use disorder (SUD), and 20.4 million had both. More

  • Health Equity Opioids

    Opioid Settlements, Big Pharma, and Racial Disparities in the Opioid Epidemic

    July 2025 Jerel M. Ezell Sugy Choi

    Despite recent overall decreases in drug overdose deaths, racial disparities are persisting. This, coming against the backdrop of sweeping national opioid settlements, offers a reminder of the enduring potency of systemic racism in the face of what is otherwise a demonstrable public health success. More

  • Health Insurance Population Health

    Medicaid Cuts Are Undemocratic and Not What the American People Want

    June 2025 Jamila Michener Sarah E. Gollust

    Americans from across the political spectrum oppose cuts to Medicaid, believe that the program is effective, and are willing to take steps to defend Medicaid. More

  • Health care costs Pharmaceutical and Medical Device Policy State Health Policy

    National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws

    June 2025 Hannah Rahim Aaron S. Kesselheim

    Prescription drug prices in the United States are substantially higher than in other high-income countries, with US prices reported to be an average of 2.78 times those of other countries in the Organisation for Economic Co-operation and Development.1 In response to these high prices, along with an opaque supply chain that can lead to substantial discrepancies in prices across different payors, states have passed drug price transparency laws that require manufacturers to disclose information on drug prices. More